Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Finasteride may help improve certain brain function issues linked to dopamine.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

The treatment was not recommended due to limited effectiveness and significant side effects.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Genetic marker rs12558842 strongly linked to male hair loss.

Puerariae Radix extract may help hair growth by increasing cell activity.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Ritlecitinib is safe and may effectively treat alopecia areata.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Correcting EDA fibronectin organization and YAP translocation can improve wound healing in fibrotic conditions.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.